Supplementary Table 2. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

Authors :: Wayne L. Furman
Alberto S. Pappo
Victor M. Santana
Rachel C. Brennan
Shenghua Mao
Jianrong Wu
William E. Janssen
Wing Leung
Catherine Y. Ng
Aaron Shafer
Michael Meagher
Paul Hutson
Jacquelyn A. Hank
Paul M. Sondel
Barry L. Shulkin
M. Beth McCarville
Sara M. Federico
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Human anti-human antibody (HAHA) level and peak hu14.18K322A serum level by course and prior antibody therapy.

Tools